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qhis publication is to inform visitors of the full
equirements for entry into Saudi Arabia. The Min-
stry of Health of Saudi Arabia has issued the
ollowing requirements and recommendations for
ntry visas for the Hajj and Umra seasons in 2011
ellow Fever
) In accordance with the International Health
egulations 2005 [1], all travellers arriving from
ountries or areas at risk of yellow fever (listed
elow) must present a valid yellow fever vacci-
ation certiﬁcate showing that the person was
accinated at least 10 days previously and not more
han 10 years before arrival at the border.
In the absence of such a certiﬁcate, the individ-
al will be placed under strict surveillance for 6
ays from the date of vaccination or the last date
f potential exposure to infection, whichever is
arlier. Health ofﬁces at entry points will be respon-
ible for notifying the appropriate Director General
f Health Affairs in the region or governorate about
he temporary place of residence of the visitor.
The following countries/areas are at risk of
ellow fever transmission (as deﬁned by the Inter-
ational travel and health 2011 [2])
Africa:
Angola, Benin, Burkina Faso, Burundi, Cameroon,
entral African Republic, Chad, Congo, Cote
’Ivoire, Democratic Republic of the Congo, Equa-
orial Guinea, Ethiopia, Gabon, Guinea, Guinea
issau, Gambia, Ghana, Kenya, Liberia, Mali, Mau-
 This report will appear in WHO publication WER, issue no.
9, Volume 86, scheduled for release 23 September 2011.
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876-0341/$ — see front matter © 2011 Published by Elsevier Limited on behalf of
oi:10.1016/j.jiph.2011.07.001itania, Niger, Nigeria, Rwanda, Senegal, Sierra
eone, Sudan, Togo and Uganda
South and Central America:
Argentina, Bolivarian Republic of Venezuela,
razil, Colombia, Ecuador, French Guiana, Guyana,
anama, Paraguay, Peru, Plurinational State of
olivia, Suriname, Trinidad and Tobago
b) Aircrafts, ships and other means of transporta-
ion coming from countries affected by yellow fever
re requested to submit a certiﬁcate indicating that
t applied disinsection in accordance with methods
ecommended by WHO.
In accordance with the International Health Reg-
lations 2005, all arriving ships will be requested to
rovide to the competent authority a valid Ship San-
tation Certiﬁcate. Ships arriving from areas at risk
or yellow fever transmission may also be required
o submit to inspection to ensure they are free of
ellow fever vectors, or disinsected, as a condition
f granting free pratique (including permission to
nter a port, to embark or disembark and to dis-
harge or load cargo or stores).
eningococcal Meningitis
) Visitors from all countries:
Visitors arriving for the purpose of Umra or
ilgrimage or for seasonal work are required to
roduce a certiﬁcate of vaccination with the
uadrivalent (ACYW135) vaccine against meningi-
is issued not more than 3 years previously and not
ess than 10 days before arrival in Saudi Arabia. The
esponsible authorities in the visitor’s country of
rigin should ensure that adults and children over
he age of 2 years are given 1 dose of the quadriva-
ent polysaccharide (ACYW135) vaccine.
King Saud Bin Abdulaziz University for Health Sciences. All rights reserved.
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b) Visitors from African Countries
For Visitors arriving from countries in the
African meningitis belt, namely Benin, Burkina
Faso, Cameroon, Chad, Central African Republic,
Côte d’Ivoire, Eritrea, Ethiopia,Gambia, Guinea,
Guinea-Bissau, Mali, Niger, Nigeria, Senegal and
Sudan,in addition to the above stated require-
ments, ciproﬂoxacin tablets (500mg) chemopro-
phylaxis will be administered at port of entry to
lower the rate of carriers.
c) Interior pilgrims and the Hajj
And the Hajj workers Vaccination with quadriva-
lent (ACYW135) vaccine is required for:
— all citizens and residents of Medina and Mecca
who have not been vaccinated during the past 3
years;
— all citizens and residents undertaking the Hajj;
— all Hajj workers who have not been vaccinated
in the past 3 years;
— any individual working at entry points or in direct
contact with pilgrims in Saudi Arabia.
Poliomyelitis
All travellers arriving from polio-endemic countries
and re-established transmission countries, namely,
Afghanistan, Angola, Chad, the Democratic Repub-
lic of Congo, India, Nigeria, Pakistan and Sudan,
regardless of age and vaccination status, should
receive 1 dose of OPV. Proof of OPV vaccination at
least 6 weeks prior departure is required to apply
for entry visa for Saudi Arabia. These travellers will
also receive 1 dose of OPV at borders points on
arrival in Saudi Arabia.
All visitors age under 15 years travelling to
Saudi Arabia from countries with imported cases of
poliomyelitis in the past 12 months (see list below)
should be vaccinated against poliomyelitis with the
oral polio vaccine (OPV). Proof of OPV vaccination
is required 6 weeks prior the application for entry
visa. Irrespective of previous immunization history,
all visitors under 15 years arriving in Saudi Arabia
will also receive a dose of OPV at border points.
The following are countries with imported cases
in the past 12 months: Burkina Faso, Cote d’Ivoire,
Congo, Gabon, Guinea, Kazakhstan, Liberia, Mali,
Mauritania, Nepal, Niger, Russian Federation, Sene-
gal, Sierra Leone, Somalia, Tajikistan, Turkmenistan
and Uganda.Seasonal Inﬂuenza
The Ministry of Health of Saudi Arabia recommends
that international pilgrims be vaccinated against
n
t
b
rEditorial
easonal inﬂuenza before arrival into the king-
om of Saudi Arabia with WHO approved strains
peciﬁc to the northern or southern hemispheres,
articularly those with preexisting conditions (e.g.
he elderly over 65 years of age, people with
eurological diseases, chronic respiratory or heart
iseases or cardiac,hepatic or renal failure, dia-
etes), obesity, immunodeﬁciency (e.g. due to HIV
r cancer treatment), metabolic diseases and preg-
ant women.
In Saudi Arabia, seasonal inﬂuenza vaccine is rec-
mmended for internal pilgrims, particularly those
ith pre-existing health conditions, and all staff
orking in the Hajj premises.
ealth Education
ealth authorities in countries of origin are
equired to provide information to pilgrims on
nfectious diseases symptoms, methods of transmis-
ion, complications, and means of prevention.
ood
ajj and Umrah performers are not allowed to bring
resh food in Saudi Arabia. Only properly canned or
ealed food or food stored in containers with easy
ccess for inspection is allowed in small quantities,
ufﬁcient for one person for the duration of his or
er trip.
nternational Outbreaks Responses
pdating immunization against vaccine-
reventable diseases in all travellers is strongly
ecommended. With the recent resurgence of
easles and rubella cases, special attention
s needed for both of these vaccines to avoid
idespread outbreaks with this virus during this
ear Hajj and Umra. Preparation for interna-
ional travel provides opportunity to review the
mmunization status of travellers. Incompletely
mmunized travellers can be offered routine
accinations recommended in national immuniza-
ion schedules (these usually include diphtheria,
etanus, pertussis, polio, measles, and mumps),
n addition to those needed for the speciﬁc travel
e.g. meningococcal vaccination for Hajj). In Inter-
ational Travel and Health 2011 WHO recommends
hat travellers ensure immunity against measles
y having at least 2 doses of vaccine and against
ubella by one dose of vaccine.
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In the event of a public health emergency of
nternational health concern, or in the case of any
isease outbreak subject to notiﬁcation under the
nternational Health Regulations 2005, the health
uthorities in Saudi Arabia will undertake additional
reventive precautions (not included in the mea-
ures mentioned above) following consultation with
HO as necessary to avoid the spread of infection
uring the pilgrimage or on return to their country
f origin.
Please address any queries to the Assistant
eputy Minister of Health for Preventive Medicine
n Saudi Arabia.
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